Sign in
Stories
Securities Fraud Lawsuits Against bluebird bio
Share
AMYLYX PHARMACEUTICALS Lawsuit Deadline ...
AVXL Lawsuit Roils Investors
AVXL Lawsuit: Deceptive Practices Expose...
Overview
API
Several law firms have filed class action lawsuits against bluebird bio, Inc. for allegedly making false statements about FDA approvals, resulting in significant stock price drops and investor losses.
Ask a question
How can investors protect themselves from potential losses due to misleading information provided by companies?
How might these lawsuits impact bluebird bio's reputation and future business operations?
What measures can companies take to avoid legal repercussions related to false statements or misleading information?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Dec 2023
Jan 2024
Feb 2024
Mar 2024
Coverage